James F. Young, Director at NOVAVAX INC (NVAX), bought 100,000 shares at $2.03 ($203K) on 2013-03-11, disclosed to the SEC on 2013-03-12.
Open-market purchase of $203k NVAX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |